TILT Holdings (TLLTF) Short-term Investments (2021 - 2022)

TILT Holdings (TLLTF) reported Short-term Investments of $10.0 million for Q3 2022, down 64.58% quarter-over-quarter from $28.2 million in Q2 2022.

TILT Holdings (TLLTF) Short-term Investments (2021 - 2022) Analysis & Trends

TILT Holdings has reported Short-term Investments for 2 years, with the latest figure at $10.0 million in Q3 2022.

For the quarter ending Q3 2022, Short-term Investments changed N/A year-over-year to $10.0 million; the trailing twelve-month figure through Sep 2022 stood at $10.0 million (changed N/A YoY), and the FY2021 full-year result was $2.7 million, changed N/A from the prior year.
Short-term Investments for Q3 2022 stood at $10.0 million, down from $28.2 million in the prior quarter.
The five-year high for Short-term Investments was $28.2 million in Q2 2022, with the low at $2.7 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	TILT Holdings	-	-	1.82 Mn

Download Data